Works matching IS 03057453 AND DT 2025 AND VI 80 AND IP 3

Results: 41
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Monitoring molecular markers associated with antimalarial drug resistance in south-east Senegal from 2021 to 2023.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 3, p. 828, doi. 10.1093/jac/dkaf006
    By:
    • Wade, Alioune;
    • Sene, Seynabou D;
    • Caspar, Emanuelle;
    • Diallo, Fatoumata;
    • Platon, Lucien;
    • Thiebaut, Lucas;
    • Pouye, Mariama N;
    • Ba, Aboubacar;
    • Thiam, Laty Gaye;
    • Fall, Magal;
    • Sadio, Bacary Djilocalisse;
    • Desamours, Ife;
    • Guerra, Noemi;
    • Hagadorn, Kelly;
    • Amambua-Ngwa, Alfred;
    • Bei, Amy K;
    • Vigan-Womas, Ines;
    • Ménard, Didier;
    • Mbengue, Alassane
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    Efficacy and safety of posaconazole and liposomal amphotericin B use for prophylaxis of invasive fungal infections in a paediatric and young adult haemato-oncological population.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 3, p. 802, doi. 10.1093/jac/dkae479
    By:
    • Chiusaroli, Lorenzo;
    • Barbieri, Elisa;
    • Dell'Anna, Lucia;
    • Petris, Maria Grazia;
    • Liberati, Cecilia;
    • Reggiani, Giulia;
    • Pieri, Marica De;
    • Mengato, Daniele;
    • Marzollo, Antonio;
    • Gabelli, Maria;
    • Giaquinto, Carlo;
    • Biffi, Alessandra;
    • Donà, Daniele
    Publication type:
    Article
    20
    21
    22
    23
    24

    High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 3, p. 767, doi. 10.1093/jac/dkae472
    By:
    • Choga, Ontlametse T;
    • Lemogang, Goitseone M;
    • Choga, Wonderful T;
    • Muzanywa, Gaonyadiwe;
    • Shadreck, Thembinkosi M;
    • Ralegoreng, Charity;
    • Maruapula, Dorcas;
    • Moraka, Natasha O;
    • Koofhethile, Catherine K;
    • Mokgethi, Patrick T;
    • Seru, Kedumetse;
    • Zuze, Boitumelo J L;
    • Montshosi, Patience;
    • Gobe, Irene;
    • Motswaledi, Modisa S;
    • Musonda, Rosemary;
    • Mbulawa, Mpaphi B;
    • Makhema, Joseph;
    • Shapiro, Roger;
    • Lockman, Shahin
    Publication type:
    Article
    25

    Quantification of maternal and fetal valaciclovir exposure in a pharmacokinetic study of cytomegalovirus-infected pregnant women treated to prevent vertical transmission.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 3, p. 760, doi. 10.1093/jac/dkae470
    By:
    • Faure-Bardon, Valentine;
    • Bouazza, Naïm;
    • Benaboud, Sihem;
    • Foissac, Frantz;
    • Rouillon, Steeve;
    • Froelicher-Bournaud, Léo;
    • Leruez-Ville, Marianne;
    • Guilleminot, Tiffany;
    • Lui, Gabrielle;
    • Tréluyer, Jean-Marc;
    • Ville, Yves
    Publication type:
    Article
    26
    27
    28
    29

    Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 3, p. 731, doi. 10.1093/jac/dkae465
    By:
    • Clemente, Tommaso;
    • Diotallevi, Sara;
    • Minisci, Davide;
    • Biagio, Antonio Di;
    • Lolatto, Riccardo;
    • Attala, Letizia;
    • Cenderello, Giovanni;
    • Siribelli, Alessia;
    • Muccini, Camilla;
    • Caputo, Sergio Lo;
    • Tavio, Marcello;
    • Borjesson, Rebecka Papaioannu;
    • Giacomelli, Andrea;
    • Castagna, Antonella;
    • Spagnuolo, Vincenzo;
    • Group, PRESTIGIO Study
    Publication type:
    Article
    30
    31
    32
    33
    34

    Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 3, p. 697, doi. 10.1093/jac/dkae458
    By:
    • Soulie, Cathia;
    • Agher, Rachid;
    • Fauchois, Antoine;
    • Abdi, Basma;
    • Wirden, Marc;
    • Teyssou, Elisa;
    • Sayon, Sophie;
    • Katlama, Christine;
    • Valantin, Marc-Antoine;
    • Tubiana, Roland;
    • Schneider, Luminita;
    • Faycal, Antoine;
    • Palich, Romain;
    • Pourcher, Valérie;
    • Marcelin, Anne-Geneviève;
    • Calvez, Vincent
    Publication type:
    Article
    35

    Major role of dolutegravir in the emergence of the S147G integrase resistance mutation.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 3, p. 692, doi. 10.1093/jac/dkae457
    By:
    • Wirden, Marc;
    • Abdi, Basma;
    • Lambert-Niclot, Sidonie;
    • Chaix, Marie-Laure;
    • Monte, Anne De;
    • Montes, Brigitte;
    • Pallier, Coralie;
    • Bellecave, Pantxika;
    • Bouvier-Alias, Magali;
    • Raymond, Stephanie;
    • Yerly, Sabine;
    • Charpentier, Charlotte;
    • Calvez, Vincent;
    • Descamps, Diane;
    • Marcelin, Anne-Genevieve
    Publication type:
    Article
    36

    Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 3, p. 682, doi. 10.1093/jac/dkae456
    By:
    • Suárez-García, Inés;
    • Alejos, Belén;
    • Moreno, Cristina;
    • Torres, Juan Martín;
    • Masiá, Mar;
    • García-Fraile, Lucio J;
    • Riera, Melchor;
    • Dalmau, David;
    • Rodríguez-Rosado, Rafael;
    • Muga, Roberto;
    • Moreno, Santiago;
    • Jarrín, Inma;
    • cohort, the CoRIS
    Publication type:
    Article
    37
    38
    39
    40
    41